§ BIOTECHNOLOGY
USD · Biotechnology

BCAX

BICARA THERAPEUTICS INC
USDSector · Biotechnology
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
112 increased/new, 47 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
RA CAPITAL MANAGEMENT, L.P.7.3M1.5%+4%
Siren, L.L.C.5.8M3.2%+11%
Vestal Point Capital, LP5.4M3.0%+52%
Deep Track Capital, LP4.1M1.3%+55%
JANUS HENDERSON GROUP PLC3.3Mn/a+26%
RED TREE MANAGEMENT, LLC3.2M56.4%±0%
◇ AC INTELLIGENCE

Top institutional owners for BCAX as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER86.3% · 94 holders
QUALITY / COMPOUNDER18.5% · 14 holders
PASSIVE / INDEX6.4% · 7 holders
DEALER / BANK5.8% · 18 holders
TACTICAL / MACRO3.4% · 4 holders
INCOME / DEFENSIVE0.9% · 7 holders
ACTIVIST0.4% · 1 holder
GROWTH / MOMENTUM0.1% · 1 holder
SYSTEMATIC / QUANT0.1% · 3 holders
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for BCAX in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention BCAX yet.